CD8A and neoplasm: This lack of persistence was restricted to anti-tumor CD8+ T cells, because when we immunized mice against both P1A and an irrelevant antigen named P91A (an H-2Ld-restricted mutated peptide7), we observed that the CD8+ response against the latter antigen persisted in tumor-bearing mice (Fig. 1c).